AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim M 4mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Endoglim M 4mg/500mg Tablet

DiaBetaComb 4mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This treatment helps regulate blood glucose. DiaBetaComb should be ingested with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended.

Uses of Endoglim M 4mg/500mg Tablet

Managing Type 2 diabetes

Major Benefits of Endoglim M 4mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Endoglim M 4mg/500mg tablets with a meal.

Common Side effects of Endoglim M 4mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Endoglim M 4mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Endoglim M 4mg/500mg tablets should be administered with a meal.

How Endoglim M 4mg/500mg Tablet works:

Endoglim M, a 4mg/500mg tablet, unites glimepiride and metformin to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Endoglim M 4mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoglim M 4mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

The medication Endoglim M 4mg/500mg Tablet is contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Endoglim M 4mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Endoglim M 4mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim M 4mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, it's contraindicated in those with severe liver disease.

What if you forget to take Endoglim M 4mg/500mg Tablet :

Should you forget to take your Endoglim M 4mg/500mg Tablet, administer it immediately upon recollection. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoglim M 4mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Endoglim M 4mg/500mg Tablet

Retain this medication in its original, tightly sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical condition stemming from excessive blood lactic acid, is a potential adverse effect of Endoglim M 4mg/500mg Tablets. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with impaired kidney function, the elderly, and those who consume substantial alcohol. Characteristic symptoms include muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. The immediate cessation of Endoglim M 4mg/500mg Tablet use and prompt medical attention are crucial should any of these symptoms manifest.
Endoglim M, a 4mg/500mg tablet, combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used alongside a healthy diet and regular physical activity. Glimepiride's mechanism involves stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose output and improves insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Endoglim M 4mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged consumption of Endoglim M 4mg/500mg Tablets can indeed lead to Vitamin B12 deficiency. This medication impairs the body's ability to absorb Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Indeed, Endoglim M 4mg/500mg Tablets can induce hypoglycemia. Low blood sugar symptoms include nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry readily available simple sugars such as glucose tablets, honey, or fruit juice.
Consuming alcohol concurrently with Endoglim M 4mg/500mg tablets is unsafe due to the risk of significantly reduced blood glucose, potentially resulting in hypoglycemia. Furthermore, this combination may elevate the likelihood of lactic acidosis.
Endoglim M 4mg/500mg Tabl...
82
MRP 100
18% off